Exogenous glucocorticoid excess as a result of ritonavir–fluticasone interaction
- 1 January 2005
- journal article
- Published by Wiley in Internal Medicine Journal
- Vol. 35 (1), 67-68
- https://doi.org/10.1111/j.1445-5994.2004.00723.x
Abstract
No abstract availableThis publication has 8 references indexed in Scilit:
- Cushing's syndrome in a patient treated by ritonavir/lopinavir and inhaled fluticasoneHIV Medicine, 2003
- Exogenous Cushing Syndrome Mimicking Human Immunodeficiency Virus LipodystrophyClinical Infectious Diseases, 2002
- Budesonide-induced acute hepatitis in an HIV-positive patient with ritonavir as a co-medicationAIDS, 2002
- Iatrogenic Cushing's Syndrome in an HIV-Infected Patient Treated with Inhaled Corticosteroids (Fluticasone Propionate) and Low Dose Ritonavir Enhanced PI Containing RegimenJournal of Infection, 2002
- Asthma and Cushing's SyndromeChest, 2000
- Safety of Inhaled and Intranasal CorticosteroidsDrug Safety, 2000
- Systemic Adverse Effects of Inhaled Corticosteroid TherapyArchives of Internal Medicine, 1999
- Hypothalamic-Pituitary-Adrenal Axis Suppression and Inhaled Corticosteroid TherapyNeuroimmunomodulation, 1998